Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site-side software/version change with no substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:04.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:13.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:35:42.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding/operating status notice (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T12:39:25.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:35:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.